We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Biodegradable Nanoparticles Kill Drug Resistant Gram-Positive Bacteria

By LabMedica International staff writers
Posted on 20 Apr 2011
A recent paper described the development of biodegradable nanoparticles capable of killing Gram-positive bacteria including MRSA (Methicillin-resistant Staphylococcus aureus).

Investigators at the IBM Almaden Research Laboratory (San Jose, CA, USA) focused on types of nanoparticles that would be able to disrupt bacterial cell membranes. More...
They reasoned that while it only requires one to two decades for microbes to develop resistance to traditional antibiotics that target a particular metabolic pathway inside the cell, drugs that compromise microbes' cell membranes are probably less likely to evoke resistance.

In the current study, they prepared polymer nanoparticles synthesized by metal-free organocatalytic ring-opening polymerization of functional cyclic carbonate. These nanoparticles were biodegradable and possessed a secondary structure that could insert into and disintegrate bacterial and fungal cell membranes.

Data obtained in collaboration with researchers at the Singapore Institute of Bioengineering and Nanotechnology (Singapore) was published in the April 3, 2011, online edition of the journal Nature Chemistry. Results showed that the nanoparticles disrupted microbial walls and membranes selectively and efficiently, thus inhibiting the growth of Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA), and fungi, without inducing significant hemolysis over a wide range of concentrations.

The biodegradable nanoparticles, which can be synthesized in large quantities and at low cost, represent a promising new class of antimicrobial drugs.

"We are trying to generate polymers that interact with microbes in a very different way than traditional antibiotics,” said contributing author Dr. James Hedrick, a materials scientist at the IBM Almaden Research Laboratory.

Related Links:
IBM Almaden Research Laboratory
Singapore Institute of Bioengineering and Nanotechnology


New
Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
New
Automated Biochemical Analyzer
iBC 900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Platelets sequester cfDNA during circulation (Murphy L. et al., Science, 2025; DOI: 10.1126/science.adp3971)

Platelets Could Improve Early and Minimally Invasive Detection of Cancer

Platelets are widely recognized for their role in blood clotting and scab formation, but they also play a crucial role in immune defense by detecting pathogens and recruiting immune cells.... Read more

Immunology

view channel
Image: Prof. Nicholas Schwab has found a biomarker that can predict treatment outcome of glatirameracetate in MS patients (Photo courtesy of Uni MS - M. Ibrahim)

Simple Genetic Testing Could Predict Treatment Success in Multiple Sclerosis Patients

Multiple sclerosis (MS) patients starting therapy often face a choice between interferon beta and glatiramer acetate, two equally established and well-tolerated first-line treatments. Until now, the decision... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
Image: (A) Normal skin and (B) possible pathology in ALS skin (Photo courtesy of Biomolecules and Biomedicine (2025) DOI: 10.17305/bb.2025.12100)

Skin-Based Biomarkers to Enable Early Diagnosis of Amyotrophic Lateral Sclerosis

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that damages motor neurons in the brain and spinal cord, causing muscle weakness, paralysis, and death within three to five... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.